ArticleCureus2022
Leveraging Advanced Data Analytics to Predict the Risk of All-Cause Seven-Day Emergency Readmissions.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Predicting Readmission Among High-Risk Discharged Patients Using a Machine Learning Model With Nursing Data: Retrospective Study.JMIR medical informatics · 2025Article
- A Machine Learning Model for Predicting the Risk of Readmission in Community-Acquired Pneumonia.Cureus · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Emergency readmissions have been a long-time, multifaceted, unsolved problem. Developing a predictive model calibrated with hospital-specific Electronic Health Record (EHR) data could give higher prediction accuracy and insights into high-risk patients for readmission. Thus, we need to proactively introduce the necessary interventions. This study aims to investigate the relationship between features that consider significant predictors of at-risk patients for seven-day readmission through logistic regression in addition to developing several machine learning models to test the predictability of those attributes using EHR data in a Saudi Arabia-specific ED context. Methods Univariate and multivariate logistic regression has been used to identify the most statistically significant features that contributed to classifying readmitted and not readmitted patients. Seven different machine learning models were trained and tested, and a comparison between the best-performing model was conducted in terms of five performance metrics. To construct the prediction model and internally validate it, the processed dataset was split into two sets: 70% for the training set and 30% for the test set or validation set. Results XGBoost achieved the highest accuracy (64%) in predicting early seven-day readmissions. Catboost was the second-best predictive model at 61%. XGBoost achieved the highest specificity at 70%, and all the models had a sensitivity of 57% except for XGBoost and Catboost at 32% and 38%, respectively. All predictive attributes, patient age, length of stay (LOS) in minutes, visit time (AM), marital status (married), number of medications, and number of abnormal lab results were significant predictors of early seven-day readmissions while marital status and number of vital-sign instabilities at discharge were not statistically significant predictors of seven-day readmission. Conclusion Although XGBoost and Catboost showed good accuracy, none of the models achieved good discriminative ability in terms of sensitivity and specificity. Thus, none can be clinically used for predicting early seven-day readmission. More predictive variables need to be fed into the model, specifically predictors approximate to the day of discharge, in order to optimize the model's performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.